REVERSIBLE NUKLEOTIDE ÄNDERUNG

Patent europeic · EP4265628 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4265628
Numer da la dumonda
EP23179549
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-09-2020
Publitgà
25-10-2023
Concedì
05-11-2025
La protecziun finescha il pli tard
09-09-2040
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
C07H 19/00 (2006.01)
C07H 21/00 (2006.01)
C07H 1/00 (2006.01)
C07H 19/10 (2006.01)
C07H 19/20 (2006.01)
Prioritad
US 201962898152 P 10.09.2019
Derivà da
EP20776287
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 16-09-2026

    Midada

    Published in Swissreg on 16.09.2026

  2. 05-11-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 05.11.2025

Partidas

Possessur

Pacific Biosciences of California, Inc.

1305 O'Brien Drive, Menlo Park, CA 94025, US

Inventur

MALYSHEV, Denis

San Diego, CA 6965, US

FELDMAN, Aaron W.

San Diego, CA 6965, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.